Full Time Trials Pharmacist at King’s College London Required

jobs pharmaguidelines; London; On-site; GBP 51,000 - 62,000; Full time

Job summary

A clinical trials organization in London is seeking a Trials Pharmacist to manage Investigational Medicinal Products (IMPs) for clinical trials. Responsibilities include providing support to Chief Investigators, overseeing stock levels, and ensuring compliance with regulations. Candidates must have a Master's in pharmacy, GPhC registration, and significant clinical trials experience. This role offers a full-time permanent contract with a competitive salary and potential travel across the UK.

Qualifications

• Qualified pharmacist required with clinical trials experience.
• Understanding of clinical trials legislation is essential.

Responsibilities

• Provide specialist IMP management support to Chief Investigators.
• Maintain adequate stock levels of IMPs.
• Manage communications between stakeholders.

Skills

Clinical trials experience

Problem-solving skills

Organisational skills

Communication skills

IT skills

Education

Master's degree in pharmacy

Registration with GPhC

Post-graduate Diploma in Clinical Pharmacy

Job description

Location: London
Salary: £51,974 to £61,021 per annum, including London Weighting Allowance
Hours: Full Time
Contract Type: Permanent
Placed On: 4th July 2024
Closes: 16th July 2024
Job Ref: 092225

About Us

King’s Clinical Trials Unit (KCTU) manages a diverse portfolio of clinical trials, both medicinal and non-medicinal. We are dedicated to providing support to investigators for the efficient and cost-effective delivery of trials. Our commitment is to streamline processes and avoid unnecessary bureaucracy, ensuring the responsible use of public funds.

About the Role

As a Trials Pharmacist, you will join the pharmacy section of our operational team, providing Investigational Medicinal Product (IMP) management support to Chief Investigators. Your responsibilities will include identifying and agreeing on requirements for active and comparator IMPs, discussing blinding options, sourcing suppliers, and overseeing manufacturing plans. Additionally, you will develop and deliver operational plans to support multicentre trials in compliance with relevant regulations.

Key Responsibilities:

• Provide specialist IMP management support to Chief Investigators.
• Maintain adequate stock levels of IMPs at manufacturers, vendors, and study sites throughout the project lifecycle.
• Manage communications between Chief Investigators and manufacturers.
• Collaborate with contracts teams, Sponsors, and Trial Managers to ensure effective IMP management in clinical trials.

About You

To succeed in this role, you must be a qualified pharmacist with substantial clinical trials experience in hospital, academia, or industry settings. A thorough understanding of clinical trials legislation is essential.

Essential Criteria:

• Master’s degree in pharmacy or equivalent.
• Registration with the General Pharmaceutical Council of Great Britain (GPhC).
• Post-graduate Diploma in Clinical Pharmacy or equivalent.
• Experience as a Clinical Trials Pharmacist.
• Knowledge of IMP legislation and guidance.
• Proven problem-solving skills.
• Excellent organisational, IT, and communication skills.
• Ability to work independently and as part of a team.
• Self-motivation and the ability to motivate others.

Desirable Criteria:

• Experience reviewing drug supply agreements and technical/quality agreements.
• Line management experience.
• Project management experience.

Additional Information

This full-time position (35 hours per week) offers an indefinite contract. The primary location is Denmark Hill, with potential travel to other locations for project meetings within King’s Health Partners (KHP) and occasionally across the UK and overseas.

Application Process

For full details on the role, skills, knowledge, and experience required, please refer to the Job Description available via the ‘Apply’ button. This document outlines the criteria to be assessed at each recruitment stage.

Closing Date: 16th July 2024